GASTRIN-RELEASING PEPTIDE PRECURSOR INCREASED

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting GASTRIN-RELEASING PEPTIDE PRECURSOR INCREASED:

# Drug Count
0 CARBOPLATIN 6
1 ETOPOSIDE 6
2 ATEZOLIZUMAB 2
3 DURVALUMAB 2
4 OSILODROSTAT 2
5 OSIMERTINIB 2
6 PEGFILGRASTIM 2
7 ANTI ITCH 1
8 ANTI-ITCH 1
9 ANTI-ITCH CREAM 1
See all common drugs associated with GASTRIN-RELEASING PEPTIDE PRECURSOR INCREASED

GASTRIN-RELEASING PEPTIDE PRECURSOR INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OSILODROSTAT 2 0.0009
1 PEGFILGRASTIM 2 0.0002
2 TOPOTECAN 1 0.0002
3 VANCOMYCIN HYDROCHLORIDE 1 0.0001
4 GEFITINIB 1 0.0001
5 DURVALUMAB 2 0.0001
6 ETOPOSIDE 6 0.0001
7 LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN 1 0.0001
8 GENTAMICIN SULFATE 1 0.0001
9 OSIMERTINIB 2 0.0001
See all drugs enriched for association with GASTRIN-RELEASING PEPTIDE PRECURSOR INCREASED